Differences in morbidity and mortality between unilateral adrenalectomy for adrenal Cushing's syndrome and bilateral adrenalectomy for therapy refractory extra-adrenal Cushing's syndrome.
Adrenal surgery
Complication
Cushing
MTL30
Journal
Langenbeck's archives of surgery
ISSN: 1435-2451
Titre abrégé: Langenbecks Arch Surg
Pays: Germany
ID NLM: 9808285
Informations de publication
Date de publication:
Sep 2022
Sep 2022
Historique:
received:
04
03
2022
accepted:
21
05
2022
pubmed:
29
5
2022
medline:
15
9
2022
entrez:
28
5
2022
Statut:
ppublish
Résumé
In selected cases of severe Cushing's syndrome due to uncontrolled ACTH secretion, bilateral adrenalectomy appears unavoidable. Compared with unilateral adrenalectomy (for adrenal Cushing's syndrome), bilateral adrenalectomy has a perceived higher perioperative morbidity. The aim of the current study was to compare both interventions in endogenous Cushing's syndrome regarding postoperative outcomes. We report a single-center, retrospective cohort study comparing patients with hypercortisolism undergoing bilateral vs. unilateral adrenalectomy during 2008-2021. Patients with adrenal Cushing's syndrome due to adenoma were compared with patients with ACTH-dependent Cushing's syndrome (Cushing's disease and ectopic ACTH production) focusing on postoperative morbidity and mortality as well as long-term survival. Of 83 patients with adrenalectomy for hypercortisolism (65.1% female, median age 53 years), the indication for adrenalectomy was due to adrenal Cushing's syndrome in 60 patients (72.2%; 59 unilateral and one bilateral), and due to hypercortisolism caused by Cushing's disease (n = 16) or non-pituitary uncontrolled ACTH secretion of unknown origin (n = 7) (27.7% of all adrenalectomies). Compared with unilateral adrenalectomy (n = 59), patients with bilateral adrenalectomy (n = 24) had a higher rate of severe complications (0% vs. 33%; p < 0.001) and delayed recovery (median: 10.2% vs. 79.2%; p < 0.001). Using the MTL30 marker, patients with bilateral adrenalectomy fared worse than patients after unilateral surgery (MTL30 positive: 7.2% vs. 25.0% p < 0.001). Postoperative mortality was increased in patients with bilateral adrenalectomy (0% vs. 8.3%; p = 0.081). While unilateral adrenalectomy for adrenal Cushing's syndrome represents a safe and definitive therapeutic option, bilateral adrenalectomy to control ACTH-dependent extra-adrenal Cushing's syndrome or Cushing's disease is a more complicated intervention with a mortality of nearly 10%.
Identifiants
pubmed: 35633419
doi: 10.1007/s00423-022-02568-8
pii: 10.1007/s00423-022-02568-8
pmc: PMC9467939
doi:
Substances chimiques
Adrenocorticotropic Hormone
9002-60-2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2481-2488Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Gastric Cancer. 2021 Jul;24(4):959-969
pubmed: 33576929
Compr Physiol. 2014 Apr;4(2):739-69
pubmed: 24715566
J Clin Endocrinol Metab. 2009 Sep;94(9):3365-71
pubmed: 19509101
Eur J Endocrinol. 2020 Apr;182(4):R29-R58
pubmed: 31999619
PLoS One. 2020 Aug 28;15(8):e0238473
pubmed: 32857807
Br J Surg. 2021 Sep 27;108(9):1112-1119
pubmed: 33990837
Rev Endocr Metab Disord. 2010 Jun;11(2):117-26
pubmed: 20544290
Int J Surg. 2021 Feb;86:24-31
pubmed: 33429078
Eur J Endocrinol. 2015 Oct;173(4):M23-32
pubmed: 25994948
Chirurg. 2017 Nov;88(11):977-982
pubmed: 28761965
J Clin Endocrinol Metab. 2001 Jan;86(1):117-23
pubmed: 11231987
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Best Pract Res Clin Endocrinol Metab. 2019 Oct;33(5):101296
pubmed: 31331729
Dtsch Arztebl Int. 2019 Nov 1;116(44):739-746
pubmed: 31774053
Clin Epidemiol. 2015 Apr 17;7:281-93
pubmed: 25945066
BJS Open. 2020 Apr;4(2):310-319
pubmed: 32207577
Endocr Rev. 1994 Dec;15(6):752-87
pubmed: 7705280
BJS Open. 2019 May 03;3(5):672-677
pubmed: 31592096
Ann Surg Oncol. 2020 Oct;27(10):3851-3857
pubmed: 32388739
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
Endocr Rev. 2015 Aug;36(4):385-486
pubmed: 26067718
Surgery. 2001 Oct;130(4):629-34; discussion 634-5
pubmed: 11602893
Ann N Y Acad Sci. 2002 Sep;970:134-44
pubmed: 12381548
J Clin Endocrinol Metab. 2013 Oct;98(10):3939-48
pubmed: 23956347
Ann Surg. 2009 Aug;250(2):187-96
pubmed: 19638912
J Clin Endocrinol Metab. 2013 Jun;98(6):2277-84
pubmed: 23533241